BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Witkowsky O, Teuteberg J, Althouse AD, Shullo M. Thrombotic events with proliferation signal inhibitor‒based immunosuppression in cardiac transplantation. J Heart Lung Transplant 2019;38:619-26. [PMID: 30685236 DOI: 10.1016/j.healun.2019.01.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Mallah SI, Atallah B, Moustafa F, Naguib M, El Hajj S, Bader F, Mehra MR. Evidence-based pharmacotherapy for prevention and management of cardiac allograft vasculopathy. Progress in Cardiovascular Diseases 2020;63:194-209. [DOI: 10.1016/j.pcad.2020.03.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Bellumkonda L, Patel J. Recent advances in the role of mammalian target of rapamycin inhibitors on cardiac allograft vasculopathy. Clin Transplant 2019;34. [DOI: 10.1111/ctr.13769] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Almufleh A, Zhang L, Mielniczuk LM, Stadnick E, Davies RA, Du Q, Rayner K, Liu PP, Chih S. Biomarker discovery in cardiac allograft vasculopathy using targeted aptamer proteomics. Clin Transplant 2019;34. [DOI: 10.1111/ctr.13765] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
4 Fortich S, Ritchie C, Shaikh ME, Toskich B, Rivera CE, Erben Y. Deep vein thrombosis in the setting of Klippel-Trenaunay syndrome and sirolimus treatment. J Vasc Surg Cases Innov Tech 2021;7:524-8. [PMID: 34401617 DOI: 10.1016/j.jvscit.2021.06.014] [Reference Citation Analysis]